Central Nervous System Toxicity After Botulinum Neurotoxin Injection
Authors
Abstract
Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-year-old woman with Parkinsons disease who received BoNT injections to treat painful spasticity in her hands. She developed severe generalized dystonia shortly after BoNT injections.
Copyright
© 2013, Author(s). The Author(s) retain copyright in the Article. Upon acceptance, the Author(s) grant Brieflands the non-exclusive right of first publication and a worldwide, perpetual, royalty-free, non-exclusive license to copyedit, format, publish, reproduce, distribute, display, preserve, archive, index, promote, and make the Version of Record available in all formats and media. Brieflands and the relevant journal will be identified as the original publisher of the Version of Record. The Article will be published under the [Creative Commons Attribution 4.0 International License (CC BY 4.0)](https://creativecommons.org/licenses/by/4.0/). The Author(s) may immediately deposit and share the Version of Record in any repository or platform. No separate permission or fee is required for uses permitted under CC BY 4.0. CCC may provide optional customized reprint services.
Similar Articles
Paresis Following Type A Botulinum Toxin (Dysport) Injection: A Case Report
Salarian S, Raoufi M, Asgari S, Behnaz F, Safarpour Lima B. Paresis Following Type A Botulinum Toxin (Dysport) Injection: A Case Report. J Cell Mol Anesth. 2024;9(2):e146536. doi: https://doi.org/10.5812/jcma-146536
Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain
Jazayeri SM, Ashraf A, Fini HM, Karimian H, Nasab MV. Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain. Anesth Pain Med. 2011;1(2):77-80. doi: https://doi.org/10.5812/kowsar.22287523.1845
Complications of Botulinum Toxin-A Injection in an Iranian Population
Afrozandeh M, Heydariyan A, Azizian Z. Complications of Botulinum Toxin-A Injection in an Iranian Population. J Skin Stem Cell. 2017;4(2):e63334. doi: https://doi.org/10.5812/jssc.63334
Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
Emami Razavi SZ, Azadvari M, Mirmosayyeb O, Vaheb S, Ghajarzadeh M, et al. Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis. Middle East J Rehabil Health Stud. 2025;12(2):e156825. doi: https://doi.org/10.5812/mejrh-156825
Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy
Hematti H, Izadi S, Molaei A. Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy. J Microbiota. 2023;1(1):e143022. doi: https://doi.org/10.5812/jmb-143022
- Scopus by DOI: 6
Last Update: 3 weeks ago
- Scopus by Title: 6
Last Update: 3 weeks ago
- Scopus by Title (Ref): 6
Last Update: 3 weeks ago
- CrossRef: 4
Last Update: 4 days ago